These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 361628)

  • 21. Pathogenesis of recurrent urinary tract infection: use of understanding as therapy.
    Schaeffer AJ
    Urology; 1988 Aug; 32(2 Suppl):13-6. PubMed ID: 3043880
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Changes in pools of autoantibodies and anti-bacterial antibodies in patients suffering from recurrent infections of the urinary tract and undergoing bacterial immunization treatment.
    Stojanović M; Inić-Kanada A; Popović Z; Zivković I; Dimitrijević L
    Immunol Lett; 2004 Jun; 94(1-2):123-33. PubMed ID: 15234544
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Intravesical hyaluronic acid and chondroitin sulfate alone and in combination for urinary tract infection: assessment of protective effects in a rat model.
    Tasdemir S; Tasdemir C; Vardi N; Yakupogullari Y; Duman Y; Parlakpinar H; Sagir M; Acet A
    Int J Urol; 2012 Dec; 19(12):1108-12. PubMed ID: 22852837
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The effects of oral and combined parenteral/oral immunization against an experimental Escherichia coli urinary tract infection in mice.
    Layton GT; Smithyman AM
    Clin Exp Immunol; 1983 Nov; 54(2):305-12. PubMed ID: 6360434
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of urine concentration versus tissue concentration of ampicillin and mecillinam on bacterial adherence in the rat bladder.
    Frimodt-Møller N; Maigaard S; Madsen PO
    Invest Urol; 1981 Mar; 18(5):322-5. PubMed ID: 6259079
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Urothelial hyperplasia and neoplasia. III. Detection of nitrosamine production with different bacterial genera in chronic urinary tract infections of rats.
    Davis CP; Cohen MS; Hackett RL; Anderson MD; Warren MM
    J Urol; 1991 Apr; 145(4):875-80. PubMed ID: 2005721
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Evaluation of virulence factors and the adhesive capability of Escherichia coli strains.
    Savoia D; Millesimo M; Fontana G
    Microbios; 1994; 80(323):73-81. PubMed ID: 7898375
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Changes in composition of IgM polymers in patients suffering from recurrent urinary bacterial infections after bacterial immunization treatment.
    Petrušić V; Stojanović M; Zivković I; Inić-Kanada A; Dimitrijević L
    Immunol Invest; 2010; 39(8):781-95. PubMed ID: 20718658
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparison of three techniques for the diagnosis of urinary tract infections in dogs with urolithiasis.
    Gatoria IS; Saini NS; Rai TS; Dwivedi PN
    J Small Anim Pract; 2006 Dec; 47(12):727-32. PubMed ID: 17201824
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Immunological approach to the pathogenetical role of Escherichia coli adhesive factor "119" in a suckling mouse urinary tract model.
    Kétyi I
    Acta Microbiol Acad Sci Hung; 1982; 29(2):123-7. PubMed ID: 6127911
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Preventive effects of hyaluronic acid on Escherichia coli-induced urinary tract infection in rat.
    Lee DG; Cho JJ; Park HK; Kim DK; Kim JI; Chang SG; Lee SJ
    Urology; 2010 Apr; 75(4):949-54. PubMed ID: 19647303
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [The role of E. coli adhesiveness in the pathogenesis and clinical course of urinary tract infections].
    Krzeska I; Ostojska J; Dzierzanowska D
    Pol Tyg Lek; 1992 Aug 7-17; 47(31-33):706-9. PubMed ID: 1362812
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Serum antibody effect on induced bladder infection.
    Uehling DT; Constant M
    Invest Urol; 1970 Jul; 8(1):62-5. PubMed ID: 4914799
    [No Abstract]   [Full Text] [Related]  

  • 34. Innate and adaptive immune responses in the urinary tract.
    Song J; Abraham SN
    Eur J Clin Invest; 2008 Oct; 38 Suppl 2():21-8. PubMed ID: 18826478
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Big differences in the resistance against urinary tract infections. Knowledge of steering mechanisms is limited].
    Svanborg C
    Lakartidningen; 1994 Sep; 91(38):3369-70. PubMed ID: 7990570
    [No Abstract]   [Full Text] [Related]  

  • 36. Antibody production in urinary tract infections in the rat.
    Heptinstall RH; Ramsden PW
    Invest Urol; 1972 Mar; 9(5):426-30. PubMed ID: 4552605
    [No Abstract]   [Full Text] [Related]  

  • 37. [Effects of vaccination in urinary infections caused by Escherichia coli in rats].
    Mathieu D; Jacques L; Auer J; Bizzini B
    Biomed Pharmacother; 1987; 41(8):442-5. PubMed ID: 3330459
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Endotracheal gentamicin for the prevention of bronchial infections in patients with tracheotomy.
    Klastersky J; Cappel R; Noterman J; Snoeck J; Geuning C; Mouawad E
    Int J Clin Pharmacol; 1973 Jul; 7(4):279-86. PubMed ID: 4199250
    [No Abstract]   [Full Text] [Related]  

  • 39. Bacterial adherence in a rat bladder augmentation model: ileocystoplasty versus colocystoplasty.
    Sakai Y; Fujisawa M; Nakano Y; Miyazaki S; Arakawa S; Kamidono S
    J Urol; 2000 Dec; 164(6):2104-7. PubMed ID: 11061936
    [TBL] [Abstract][Full Text] [Related]  

  • 40. New aspects of pathogenesis of lower urinary tract infections.
    Sobel JD
    Urology; 1985 Nov; 26(5 Suppl):11-6. PubMed ID: 3904135
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.